Powered by HealthTechMovers.com
We added 3 stocks to our Healthcare & Biotech Stock Watchlist today because they are receiving Bullish Sentiment from investors and financial bloggers.
In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention. This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.
Waters, WAT
Summary: Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division.
- Last Price: $338.88
- Price Change: -$1.67, -0.49%
- Yearly Gain: -13.07%
- Market Cap: $20.51B
- P/E Ratio: 29.697
Here are 3rd party ratings for WAT:
- TipRanks.com: Moderate Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Sell, Bottom 38% (156 out of 252)
What is the sentiment on the street regarding Waters ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: High
- Insider Signal: Neutral
- Investor Sentiment: Very Positive
- Hedge Fund signal: Very Positive
If you are interested in WAT or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on WAT before you decide to make any investment.
Click here for chart >>
Lexicon Pharmaceuticals, LXRX
Summary: Lexicon Genetics Incorporated is a leader in defining the functions of genes for drug discovery using large-scale knockout mouse technology. Lexicon has invented high-throughput gene trapping technology to discover thousands of genes and expand its OmniBank library of tens of thousands of mouse clones. The Company uses an integrated platform of functional genomictechnologies to accelerate large-scale analysis of mammalian gene function for drug discovery.
- Last Price: $2.69
- Price Change: $0.09, 3.46%
- Yearly Gain: -27.98%
- Market Cap: $477.34M
- P/E Ratio: -4.241
Here are 3rd party ratings for LXRX:
- TipRanks.com: Moderate Buy
- TradingView.com: Neutral
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: hold
- Zacks.com: Hold, Top 31% (77 out of 252)
What is the sentiment on the street regarding Lexicon Pharmaceuticals ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: High
- Insider Signal: Positive
- Investor Sentiment: Very Positive
- Hedge Fund signal: Neutral
If you are interested in LXRX or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on LXRX before you decide to make any investment.
Click here for chart >>
CymaBay Therapeutics, CBAY
Summary: CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead product candidate, arhalofenate, is being developed for the treatment of gout. CymaBay Therapeutics Inc. is based in Newark, California.
- Last Price: $3.9
- Price Change: $0.42, 12.07%
- Yearly Gain: -10.77%
- Market Cap: $294.68M
- P/E Ratio: -2.422
Here are 3rd party ratings for CBAY:
- TipRanks.com: Strong Buy
- TradingView.com: Strong Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 25% (62 out of 252)
What is the sentiment on the street regarding CymaBay Therapeutics ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Very High
- Insider Signal: Positive
- Investor Sentiment: Positive
- Hedge Fund signal: Positive
If you are interested in CBAY or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on CBAY before you decide to make any investment.
Click here for chart >>
Thanks for reading!